Skip to main content

Table 1 Baseline characteristics of all CaMos participants over 50 years and of participants with diabetes[15]

From: Fractures are increased and bisphosphonate use decreased in individuals with insulin-dependent diabetes: a 10 year cohort study

 

All CaMos participants >50 yrs (n = 7753)

Insulin-dependent diabetes (n = 98)

Non-insulin-dependent diabetes (n = 508)

Age (years); mean (SD)

66.7 (9.4)

68.0 (9.0)

69.4 (8.8)

Gender (female)

71.8%

64.3%

65.7%

Femoral neck BMD T-score; mean (SD)

-1.24 (0.99)

-0.97 (1.17)

-0.97 (1.04)

Caucasian

95.5%

93.9%

94.3%

Fracture at baseline (n;%)

2133 (27.5)

38 (38.8)

146 (28.7)

BMI; mean (SD)

27.1 (4.78)

29.73 (5.45)

29.06 (5.24)

Years since diagnosis of diabetes; mean;(SD)

N/A

15.4 (11.28)

9.64 (9.60)

Cigarette use;* n (%)

4163 (53.7)

54 (55.1)

280 (55.1)

Corticosteroid use; n(%)

415 (4.4)

12 (12.24)

33 (6.50)

Alcohol use (per wk); mean (SD)

2.88 (5.85)

1.97 (5.45)

2.27 (6.79)

  1. *ever use daily for > 6 months.
  2. oral or IV, ever use daily for > 1 month.
  3. SD: standard deviation, BMD: bone mineral density, BMI: body mass index.